OCUL logo

OCUL
Ocular Therapeutix Inc

10,685
Mkt Cap
$3.28B
Volume
2.18M
52W High
$16.44
52W Low
$5.79
PE Ratio
-10.73
OCUL Fundamentals
Price
$14.70
Prev Close
$15.41
Open
$15.43
50D MA
$11.85
Beta
1.55
Avg. Volume
2.49M
EPS (Annual)
-$1.22
P/B
10.44
Rev/Employee
$232,565.69
Loading...
Loading...
News
all
press releases
Ocular Therapeutix's (OCUL) "Buy" Rating Reaffirmed at Chardan Capital
Chardan Capital reaffirmed a "buy" rating and set a $21.00 target price on shares of Ocular Therapeutix in a research report on Tuesday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Ocular Therapeutix Stock Skyrockets On Faster FDA Path For Vision Drug
Ocular Therapeutix Inc (NASDAQ: OCUL) stock surged after announcing plans to expedite FDA submission for its wet AMD treatment.read more...
Benzinga·3d ago
News Placeholder
Ocular Therapeutix (NASDAQ:OCUL) Receives Buy Rating from Needham & Company LLC
Needham & Company LLC reaffirmed a "buy" rating and issued a $20.00 price objective on shares of Ocular Therapeutix in a report on Monday...
MarketBeat·3d ago
News Placeholder
Ocular Therapeutix (NASDAQ:OCUL) Reaches New 1-Year High - Here's Why
Ocular Therapeutix (NASDAQ:OCUL) Hits New 52-Week High - Here's Why...
MarketBeat·3d ago
News Placeholder
Ocular Therapeutix (NASDAQ:OCUL) Downgraded to Sell Rating by Wall Street Zen
Wall Street Zen downgraded shares of Ocular Therapeutix from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·6d ago
News Placeholder
Ocular Therapeutix (NASDAQ:OCUL) Trading Up 12.3% - What's Next?
Ocular Therapeutix (NASDAQ:OCUL) Shares Up 12.3% - Here's What Happened...
MarketBeat·6d ago
News Placeholder
Intech Investment Management LLC Sells 22,361 Shares of Ocular Therapeutix, Inc. $OCUL
Intech Investment Management LLC lessened its holdings in Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 19.7% during the second quarter, according to the company in its most recent 13F...
MarketBeat·14d ago
News Placeholder
Ocular Therapeutix (NASDAQ:OCUL) Earns "Buy" Rating from HC Wainwright
HC Wainwright restated a "buy" rating and issued a $19.00 price target on shares of Ocular Therapeutix in a research report on Tuesday...
MarketBeat·15d ago
News Placeholder
Ocular Therapeutix (NASDAQ:OCUL) Upgraded to "Hold" at Wall Street Zen
Wall Street Zen upgraded shares of Ocular Therapeutix from a "sell" rating to a "hold" rating in a research report on Monday...
MarketBeat·18d ago
News Placeholder
Wall Street Analysts Think Ocular Therapeutix (OCUL) Could Surge 82.48%: Read This Before Placing a Bet
The consensus price target hints at an 82.5% upside potential for Ocular Therapeutix (OCUL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·21d ago

Latest OCUL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.